Medicare Enrolled
Dr. Alfred Bilik, MD
Optician · Sarasota, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bilik from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bilik? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bilik
Dr. Alfred Bilik is an optician in Sarasota, FL, with 19 years in practice. Based on federal Medicare data, Dr. Bilik performed 8,982 Medicare services across 4,696 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bilik received a total of $5,053 from 45 pharmaceutical and/or device companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bilik is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 10% volume in FL$ $5,053 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,982
Medicare services
Top 10% in FL for optician
4,696
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~473 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 3,150 | $2 | $9 |
| Office visit, established patient (30-39 min) | 1,480 | $90 | $320 |
| Bladder ultrasound after voiding | 1,170 | $7 | $60 |
| Office visit, established patient (20-29 min) | 554 | $64 | $216 |
| Automated urinalysis | 498 | $2 | $11 |
| Office visit, established patient (10-19 min) | 254 | $40 | $129 |
| Urinalysis, manual | 228 | $3 | $11 |
| New patient office visit (45-59 min) | 228 | $118 | $501 |
| Limited ultrasound scan behind abdominal cavity | 187 | $42 | $343 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 127 | $136 | $685 |
| Ultrasound scan of pelvic region through rectum | 98 | $25 | $323 |
| Instillation of anti-cancer drug into bladder | 71 | $66 | $363 |
| Hospital follow-up visit, low complexity | 71 | $40 | $121 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 60 | $342 | $1,325 |
| Diagnostic exam of bladder and urethra using an endoscope | 57 | $179 | $668 |
| Biopsy of prostate gland | 57 | $94 | $458 |
| Initial hospital admission, moderate complexity | 49 | $105 | $421 |
| Insertion of stent in ureter using an endoscope | 45 | $118 | $521 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 42 | $24 | $107 |
| Dilation of urethra using an endoscope | 39 | $121 | $484 |
| Simple insertion of temporary bladder tube | 37 | $45 | $238 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 37 | $66 | $311 |
| Imaging of urinary tract following injection of a contrast agent | 34 | $19 | $70 |
| New patient office visit (30-44 min) | 27 | $76 | $325 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 23 | $133 | $529 |
| Exam of cervix and upper part of vagina using an endoscope | 23 | $68 | $299 |
| Placement of hormone pellet under skin | 21 | $72 | $332 |
| Injection procedure to cause erection | 21 | $64 | $292 |
| Insertion of sacral nerve neurostimulator electrode array | 21 | $341 | $1,813 |
| Unclassified drugs | 20 | $678 | $1,016 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 19 | $577 | $2,756 |
| Ultrasonic guidance for needle placement | 19 | $22 | $421 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $16 | $61 |
| Insertion of tube into ureter using an endoscope through bladder area | 18 | $102 | $440 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 18 | $41 | $165 |
| Placement of device in prostate for radiation therapy | 17 | $48 | $332 |
| Ultrasound scan of scrotum | 15 | $72 | $382 |
| Destruction of prostate tissue using radiofrequency induced heated water vapor | 14 | $267 | $1,198 |
| Injection of biodegradable material next to prostate | 14 | $132 | $527 |
| Insertion of peripheral or gastric neurostimulator generator | 14 | $68 | $535 |
| Electronic assessment of bladder emptying | 13 | $6 | $166 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | 13 | $193 | $815 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 13 | $244 | $795 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 12 | $259 | $936 |
| Insertion of device into abdomen with pressure and urine flow rate study | 12 | $137 | $415 |
| Insertion of sacral nerve neurostimulator electrode | 12 | $537 | $2,277 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 11 | $14 | $635 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
18.7% medium
80.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,053
Total received (2018-2024)
Avg $722/year across 7 years
Top 23% in FL for optician
45
Companies
174
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,960 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$93 (1.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,055
2023$637
2022$481
2021$367
2020$67
2019$559
2018$1,886
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
NeoTract Inc.
$1,321
PROCEPT BioRobotics Corporation
$347
Astellas Pharma US Inc
$347
Boston Scientific Corporation
$298
Intuitive Surgical, Inc.
$157
Aytu BioScience, Inc
$151
Endo Pharmaceuticals Inc.
$147
Caldera Medical, Inc
$142
Coloplast Corp
$137
COLOPLAST CORP
$133
180 Medical, Inc.
$133
Axonics, Inc.
$124
ABBVIE INC.
$120
Allergan Inc.
$116
PFIZER INC.
$106
Sumitomo Pharma America, Inc.
$98
Novartis Pharmaceuticals Corporation
$95
Teleflex LLC
$93
Ethicon US, LLC
$92
Janssen Biotech, Inc.
$88
TOLMAR Pharmaceuticals, Inc.
$68
KARL STORZ Endoscopy-America
$67
AbbVie Inc.
$58
Laborie Medical Technologies Corp.
$57
Wilmington Medical Supply, Inc.
$56
Bayer HealthCare Pharmaceuticals Inc.
$51
Endo USA, Inc.
$47
C. R. Bard, Inc. & Subsidiaries
$46
Myovant Sciences Inc.
$31
Merck Sharp & Dohme Corporation
$31
Dendreon Pharmaceuticals LLC
$29
Tolmar, Inc.
$28
AbbVie, Inc.
$27
Olympus America Inc.
$26
BIOPROTECT MEDICAL, INC.
$23
Avadel Specialty Pharmaceuticals, LLC
$22
CooperSurgical, Inc.
$22
Medtronic, Inc.
$19
UROVANT SCIENCES INC
$17
AngioDynamics, Inc.
$17
Antares Pharma, Inc.
$17
UroGen Pharma, Inc.
$15
BAXTER HEALTHCARE
$13
Allergan, Inc.
$13
EDAP TECHNOMED INC
$9
Top 3 companies account for 39.9% of total payments
Associated products mentioned in payments ›
AQUABEAM SYSTEM · AVEED · Androgel · Axonics · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · BOTOX - UROLOGY · BOTOX THERAPEUTIC · Bulkamid · CCU/LIGHT SOURCE/MONITOR · Da Vinci Surgical System · Desara · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL BPH · GENTLECATH · GREENLIGHT · GentleCath · INTERSTIM · JELMYTO · KEYTRUDA · LITHOCLAST · LITHOVUE · Luja Coude · MYRBETRIQ · Myrbetriq · NANOKNIFE · NEUWAVE Flex Microwave Ablation System · Natesto · Noctiva · Nubeqa · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · PROVENGE · Rezum Generator · SpaceOAR VUE System - 10mL · Spectra · SpeediCath · TELE PACK X LED · TISSEEL · TITAN · TOVIAZ · Titan · UROLIFT · UroLift · WALLACH Cryosurgical Equipment · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $56 per 100 Medicare services performed
Geographic Context
Opticians within 10 mi
133
Per 100K population
29.6
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL
2.0 mi
2.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bilik is a clinical cardiology specialist, with above-average Medicare volume (top 10% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bilik experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Bilik performed 3,150 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bilik receive payments from pharmaceutical companies?
Yes. Dr. Bilik received a total of $5,053 from 45 companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bilik's costs compare to other opticians in Sarasota?
Dr. Bilik's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bilik) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Sarasota
Browse opticians in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Opticians in FL
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in FL
Which FL opticians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc..
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology